AOA Dx vs Exai Bio
AOA Dx
Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI
56 employees · est. 2020 · Denver, United States
Exai Bio
Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis
22 employees · est. 2021 · Palo Alto, United States
AOA Dx is the older company (2020 vs 2021); AOA Dx is the larger of the two.
Side-by-Side Comparison
| Metric | AOA Dx | Exai Bio |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2021 |
| Headquarters | ||
| Headquarters | Denver, United States | Palo Alto, United States |
| Employees | ||
| Employees | 56 larger | 22 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care |
| Total Funding | ||
| Total Funding | $29.00M | $138.96M |
| Funding Rounds | ||
| Funding Rounds | 6 | 2 |
| Services | ||
| Services | AI-enabled early cancer detection, Development of cancer biomarkers, Innovative diagnostic platforms | Cancer detection through next-generation RNA-based platform, Integration of novel RNA biomarkers with AI for clinical insights, Development and application of oncRNA technology |
| Target Customers | ||
| Target Customers | Healthcare providers, Medical researchers, Women at risk of ovarian cancer, Health-conscious individuals | Healthcare professionals, Medical researchers, Cancer treatment centers, Diagnostic laboratories, Biotech investors |
| Taxonomy | ||
| Taxonomy | Early-Stage Cancer DetectionAI In HealthcareBiomarker TechnologyLiquid BiopsyOvarian Cancer DiagnosticsWomen’s Health +6 | Liquid BiopsyCancer DetectionCancer DiagnosisPersonalized MedicineRNA BiologyClinical Insights +6 |
| Website | ||
| Website | aoadx.com | exai.bio |
About AOA Dx
AOA Dx is at the forefront of innovation in the realm of early-stage cancer detection, setting new precedents in Biotechnology and Health Care. Established in 2020, the company is based in the United States and is committed to transforming women’s health via breakthrough diagnostics. The core of AO...
About Exai Bio
Exai Bio, founded in 2021, is pioneering a next-generation liquid biopsy platform to support early detection and precise diagnosis of cancer, aligning with its mission to innovatively target cancer treatment. By leveraging proprietary RNA and artificial intelligence technology, the company promises...
Also comparing in this category
Comparing more than these two?
Get AOA Dx, Exai Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does AOA Dx compare?
A PDF of AOA Dx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare AOA Dx with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AOA Dx on 10 Apr 2026, and Exai Bio on 12 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.